Elite in Acute Myeloid Leukemia (AML)
Check Dr. Bayard L. Powell's experience treating your condition:
About Dr. Bayard L. Powell

Bayard Powell is a Hematologist Oncology specialist and an Oncologist in Winston Salem, North Carolina. Powell has been practicing medicine for over 43 years and is rated as an Elite expert by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 31 other conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant. He is licensed to treat patients in North Carolina. Powell is currently accepting new patients.

His clinical research consists of co-authoring 136 peer reviewed articles and participating in 17 clinical trials in the past 15 years. In particular, he has co-authored 113 articles and participated in 7 clinical trials in the study of Acute Myeloid Leukemia (AML).


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Bayard L. Powell it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Medical Center Blvd, Winston Salem, NC 27157
Background & Education
Graduate Institution
University Of North Carolina At Chapel Hill School Of Medicine, 1980
Hematology Oncology
Internal Medicine in NC
Hospital Affiliations
Wake Forest Baptist Medical Center
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

16 Clinical Trials

A Phase III Randomized Trial of Steroids + Tyrosine Kinase Inhibitor (TKI) Induction With Chemotherapy or Blinatumomab for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL) in Adults
A Phase III, Multi-center, Open-label, Randomized Study of Oral Asciminib Versus Investigator Selected TKI in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase
A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults
An Open Label Study to Evaluate the Feasibility of CPI-613 Given With High Dose Cytarabine and Mitoxantrone in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL
A Phase I/II Study of CPI-613 and Hydroxychloroquine for Patients With High Risk MDS Who Have Failed Hypomethylating Therapy
Cytarabine Plus Continuous Infusion Daunorubicin Induction Therapy for Adults With Acute Myeloid Leukemia: A Feasibility Study With Cardiac MRI Monitoring
Combination of Azacitadine and Hematopoietic Growth Factors for Myelodysplastic Syndrome
View 12 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors